Stock listing
NASDAQ:LYCA Lycia Therapeutics, Inc. Stock
Home listing (NASDAQ) of Lycia Therapeutics, Inc.
Follow Lycia Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LYCA
$31.35 USD +0.43 (+1.4%)
Close on Nov 18, 2026
- Day range
- $30.45 – $32.85 USDNov 18, 2026
- Volume
- 383,616 sharesNov 18, 2026
- Market cap
- $1.63B USDAt the close on Nov 18, 2026 · price × 52.09M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LYCA · Home | $31.35 USD | +0.43 (+1.4%) | 383,616 | $30.45 | $32.85 | $30.45 | $30.92 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Oct 23, 2026 – Nov 18, 2026 · NASDAQ:LYCA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $31.35 | +0.43 | +1.4% | $30.45 | $32.85 | $30.45 | 383,616 | |
| $30.92 | +2.31 | +8.1% | $28.62 | $31.72 | $28.62 | 496,158 | |
| $28.61 | -2.59 | -8.3% | $31.23 | $32.40 | $28.18 | 250,870 | |
| $31.20 | -1.63 | -5.0% | $32.83 | $33.00 | $31.20 | 189,539 | |
| $32.83 | +1.39 | +4.4% | $32.00 | $33.44 | $30.90 | 496,078 | |
| $31.44 | +0.14 | +0.4% | $31.50 | $33.56 | $31.01 | 329,514 | |
| $31.30 | +0.94 | +3.1% | $30.36 | $31.57 | $29.88 | 239,518 | |
| $30.36 | -0.14 | -0.5% | $30.35 | $30.68 | $28.77 | 184,429 | |
| $30.50 | +1.70 | +5.9% | $28.91 | $31.18 | $28.91 | 369,987 | |
| $28.80 | -0.12 | -0.4% | $29.16 | $29.34 | $27.94 | 189,794 | |
| $28.92 | +1.32 | +4.8% | $27.48 | $28.92 | $26.42 | 302,649 | |
| $27.60 | +0.42 | +1.5% | $26.98 | $28.03 | $26.98 | 195,317 | |
| $27.18 | +0.78 | +3.0% | $27.14 | $27.66 | $26.01 | 270,514 | |
| $26.40 | -1.33 | -4.8% | $27.17 | $27.59 | $25.66 | 202,400 | |
| $27.73 | +2.68 | +10.7% | $25.25 | $27.83 | $24.51 | 173,100 | |
| $25.05 | -1.06 | -4.1% | $26.48 | $26.48 | $24.03 | 433,100 | |
| $26.11 | -2.74 | -9.5% | $26.51 | $28.00 | $24.63 | 426,800 | |
| $28.85 | -1.15 | -3.8% | $23.73 | $30.91 | $23.73 | 965,500 | |
| $30.00 | — | — | $28.55 | $36.49 | $22.19 | 2,284,000 |
- Ticker
- NASDAQ:LYCA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 11, 2026
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Latest news
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Nov 11, 2026
Closed $31.44 (+0.4%) on Nov 11, 2026
Financings
Public offering of shares of common stock
Oct 26, 2026
Closed: US$365.1M raised · US$18 a share · Jefferies +4
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead), Guggenheim Securities (co-lead), LifeSci Capital
Public offering of common stock
Oct 22, 2026
Announced: about US$317.5M · US$18 a share · Jefferies +4
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead), Guggenheim Securities (co-lead), LifeSci Capital
Lycia Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 3 in the last 12 months · 3 in all · newest Nov 11, 2026 · oldest 2026
Where Lycia Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LYCA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LYCA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lycia Therapeutics, Inc.